A carregar...
Resistance Emerges to Second Generation Anti-Androgens in Prostate Cancer
The appearance of a mutant androgen receptor, F876L-AR, in prostate cancer cells chronically exposed to enzalutamide or ARN-509 promotes a switch from antagonist to agonist receptor function, undermining the potential long term effectiveness of these second generation anti-androgen drugs.
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3800038/ https://ncbi.nlm.nih.gov/pubmed/24019330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-13-0405 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|